Individualizing HbA1c targets for patients with diabetes: Impact of an automated algorithm within a primary care network

Diabetic Medicine

Volumn 31, Issue 7, 2014, Pages 839-846

  Berkowitz, S A ^a,b   Atlas, S J ^a,b   Grant, R W ^c   Wexler, D J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; SULFONYLUREA; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ALGORITHM; ARTICLE; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; GLYCEMIC CONTROL; HEALTH CARE SYSTEM; HEALTH CENTER; HIGH SCHOOL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MIDDLE AGED; OBSERVATIONAL STUDY; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIVATE HEALTH INSURANCE; STANDARD; BLOOD; COMORBIDITY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EDUCATIONAL STATUS; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; METABOLISM; PRIMARY HEALTH CARE; TRENDS; UNITED STATES;

AGED; ALGORITHMS; BLOOD GLUCOSE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EDUCATIONAL STATUS; FEMALE; GLYCEMIC INDEX; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MEDICAID; MIDDLE AGED; PRECISION MEDICINE; PRIMARY HEALTH CARE; UNITED STATES;

EID: 84927689897     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12427     Document Type: Article

References (28)

1. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559.
2. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
3. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129-139.
4. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 2013; 36: S11-66.
5. Pogach L, Aron DC. Sudden acceleration of diabetes quality measures. J Am Med Assoc 2011; 305: 709-710.
6. Huang ES, Zhang Q, Gandra N, Chin MH, Meltzer DO. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis. Ann Intern Med 2008; 149: 11-19.
7. Ismail-Beigi F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ann Intern Med 2011; 154: 554-559.
8. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012; 35: 1364-1379.
9. Laiteerapong N, John PM, Nathan AG, Huang ES. Public health implications of recommendations to individualize glycemic targets in adults with diabetes. Diabetes Care 2013; 36: 84-89.
10. Hong CS, Atlas SJ, Chang Y, Subramanian SV, Ashburner JM, Barry MJ et al. Relationship between patient panel characteristics and primary care physician clinical performance rankings. J Am Med Assoc 2010; 304: 1107-1113.
11. Casalino LP, Elster A, Eisenberg A, Lewis E, Montgomery J, Ramos D. Will pay-for-performance and quality reporting affect health care disparities? Health Aff (Millwood) 2007; 26: w405-414.
12. Koopman RJ, Mainous AG 3rd, Diaz VA, Geesey ME. Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000. Ann Fam Med 2005; 3: 60-63.
13. Golden SH, Brown A, Cauley JA, Chin MH, Gary-Webb TL, Kim C et al. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors-an Endocrine Society scientific statement. J Clin Endocrinol Metab 2012; 97: E1579-1639.
14. Nichols GA, Kimes TM, Harp JB, Kou TD, Brodovicz KG. Glycemic response and attainment of A1C goals following newly initiated insulin therapy for type 2 diabetes. Diabetes Care 2012; 35: 495-497.
15. Atlas SJ, Grant RW, Ferris TG, Chang Y, Barry MJ. Patient-physician connectedness and quality of primary care. Ann Intern Med 2009; 150: 325-335.
16. Grant RW, Cagliero E, Sullivan CM, Dubey AK, Estey GA, Weil EM et al. A controlled trial of population management: diabetes mellitus: putting evidence into practice (DM-PEP). Diabetes Care 2004; 27: 2299-2305.
17. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in US diabetes care, 1999-2010. N Engl J Med 2013; 368: 1613-1624.
18. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA et al. AACE comprehensive diabetes management algorithm 2013. Endocr Pract 2013; 19: 327-336.
19. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577-1589.
20. National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI). Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-266.
21. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
22. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
23. Monami M, Lambertucci L, Lamanna C, Lotti E, Marsili A, Masotti G et al. Are comorbidity indices useful in predicting all-cause mortality in Type 2 diabetic patients? Comparison between Charlson index and disease count. Aging Clin Exp Res 2007; 19: 492-496.
24. Murphy SN, Chueh HC. A security architecture for query tools used to access large biomedical databases. Proceedings of the AMIA Symposium, 2002: 552-556. Available at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2244204/ Last accessed 15 March 2014.
25. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
26. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 2000; 321: 405-412.
27. Mathias JS, Baker DW. Developing quality measures to address overuse. J Am Med Assoc 2013; 309: 1897-1898.
28. Wang CC, Reusch JE. Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival. Am J Cardiol 2012; 110: 58B-68B.